Real-life assessment of erenumab in refractory chronic migraine with medication overuse headache

被引：0
|
作者：
Umberto Pensato
Carlo Baraldi
Valentina Favoni
Maria Michela Cainazzo
Paola Torelli
Pietro Querzani
Alessia Pascazio
Davide Mascarella
Eleonora Matteo
Simone Quintana
Gian Maria Asioli
Pietro Cortelli
Giulia Pierangeli
Simona Guerzoni
Sabina Cevoli
机构：
[1] University of Bologna,Department of Biomedical and NeuroMotor Sciences of Bologna
[2] University of Modena and Reggio Emilia,Medical Toxicology
[3] IRCCS Istituto Delle Scienze Neurologiche Di Bologna,Headache and Drug Abuse Research Centre, Department of Biomedical, Metabolic and Neural Sciences
[4] University Hospital of Parma,Headache Centre
[5] AOUPR,Department of Medicine and Surgery
[6] University of Parma,undefined
[7] Neurology Unit,undefined
[8] S. Maria Delle Croci Hospital-AUSL Romagna,undefined
来源：
Neurological Sciences | 2022年 / 43卷
关键词：
Anti-CGRP; Calcitonin gene-related peptide; OnabotulinumtoxinA; Migraine treatment; Prophylaxis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：1273 / 1280
页数：7
相关论文
共 50 条
  • [1] Real-life assessment of erenumab in refractory chronic migraine with medication overuse headache
    Pensato, Umberto
    Baraldi, Carlo
    Favoni, Valentina
    Cainazzo, Maria Michela
    Torelli, Paola
    Querzani, Pietro
    Pascazio, Alessia
    Mascarella, Davide
    Matteo, Eleonora
    Quintana, Simone
    Asioli, Gian Maria
    Cortelli, Pietro
    Pierangeli, Giulia
    Guerzoni, Simona
    Cevoli, Sabina
    NEUROLOGICAL SCIENCES, 2022, 43 (02) : 1273 - 1280
  • [2] Erenumab efficacy in chronic migraine and medication overuse: a real-life multicentric Italian observational study
    Francesca Schiano di Cola
    Renata Rao
    Salvatore Caratozzolo
    Marco Di Cesare
    Elisabetta Venturelli
    Ubaldo Balducci
    Vincenzo Sidoti
    Elisa Pari
    Chiara Costanzi
    Alfonsina di Summa
    Gabriele Johanna Sixt
    Elisabetta D’Adda
    Paolo Liberini
    Alessandro Padovani
    Neurological Sciences, 2020, 41 : 489 - 490
  • [3] Erenumab efficacy in chronic migraine and medication overuse: a real-life multicentric Italian observational study
    di Cola, Francesca Schiano
    Rao, Renata
    Caratozzolo, Salvatore
    Di Cesare, Marco
    Venturelli, Elisabetta
    Balducci, Ubaldo
    Sidoti, Vincenzo
    Pari, Elisa
    Costanzi, Chiara
    di Summa, Alfonsina
    Sixt, Gabriele Johanna
    D'Adda, Elisabetta
    Liberini, Paolo
    Padovani, Alessandro
    NEUROLOGICAL SCIENCES, 2020, 41 (SUPPL 2) : 489 - 490
  • [4] Erenumab for the preventive treatment of chronic migraine complicated with medication overuse headache: an observational, retrospective, 12-month real-life study
    Maria Michela Cainazzo
    Carlo Baraldi
    Anna Ferrari
    Flavia Lo Castro
    Luca Pani
    Simona Guerzoni
    Neurological Sciences, 2021, 42 : 4193 - 4202
  • [5] Erenumab for the preventive treatment of chronic migraine complicated with medication overuse headache: an observational, retrospective, 12-month real-life study
    Cainazzo, Maria Michela
    Baraldi, Carlo
    Ferrari, Anna
    Lo Castro, Flavia
    Pani, Luca
    Guerzoni, Simona
    NEUROLOGICAL SCIENCES, 2021, 42 (10) : 4193 - 4202
  • [6] Chronic migraine: Medication overuse headache
    Rothrock, John F.
    HEADACHE, 2007, 47 (03): : 467 - 468
  • [7] Effectiveness of erenumab in chronic migraine patients with associated medication overuse headache: a prospective observational study
    Curone, Marcella
    Tullo, Vincenzo
    Bussone, Gennaro
    NEUROLOGICAL SCIENCES, 2020, 41 (SUPPL 2) : 509 - 510
  • [8] Real-Life Experience with Erenumab Therapy in the Episodic and Chronic Migraine
    Alshawaf, Fatemah
    Ahmed, Samar
    Alroughani, Raed
    Al-Hashel, Jasem
    NEUROLOGY, 2023, 100 (17)
  • [9] Overview on effectiveness of erenumab, fremanezumab, and galcanezumab in reducing medication overuse headache in chronic migraine patients
    Curone, Marcella
    Tullo, Vincenzo
    Didier, Henri Albert
    Bussone, Gennaro
    NEUROLOGICAL SCIENCES, 2022, 43 (09) : 5759 - 5761
  • [10] Overview on effectiveness of erenumab, fremanezumab, and galcanezumab in reducing medication overuse headache in chronic migraine patients
    Marcella Curone
    Vincenzo Tullo
    Henri Albert Didier
    Gennaro Bussone
    Neurological Sciences, 2022, 43 : 5759 - 5761
12345